Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend
Mandate

Vinge advises Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend

May 30, 2013

Vinge has advised Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend, one of Norway’s largest veterinary clinics. A joint project is planned for the construction of a new veterinary hospital in Bergen. Djursjukhusgruppen is the Nordic region’s leading group of companies providing advanced veterinary care for dogs, cats and other pets.

Vinge’s team consisted of responsible partner Jonas Bergström together with, among others, associates Alexandra Kempe, Magnus Wieslander and Gustav Jönsson.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026

Vinge has advised IK Partners in connection with the acquisition of Selatek

 Vinge has advised IK Partners (“IK”) in connection with IK X Fund’s acquisition of SELATEK Holding AB (“Selatek”), a leading Swedish technical installation platform, from Amplio Private Equity AB and the minority shareholders.
April 20, 2026